f508del

cystic fibrosis transmembrane conductance regulator ; Mus musculus







40 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35413967 Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice. 2022 Apr 12 1
2 34034984 VIP reduction in the pancreas of F508del homozygous CF mice and early signs of Cystic Fibrosis Related Diabetes (CFRD). 2021 Sep 1
3 30874543 Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis. 2019 Mar 15 1
4 30969810 Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR. 2019 Jul 1 9
5 31189070 Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis. 2019 Dec 1
6 31251792 Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis. 2019 1
7 31427400 ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel. 2019 Oct 1
8 28196856 Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms. 2017 Jun 1 1
9 26769674 Genetic deletion of keratin 8 corrects the altered bone formation and osteopenia in a mouse model of cystic fibrosis. 2016 Apr 1 7
10 26976279 Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis. 2016 Dec 5
11 27663991 Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931. 2016 Nov 1 1
12 24974227 Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking. 2015 Jan 2
13 26092868 Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice. 2015 Jun 19 1
14 24529904 Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis. 2014 Apr 3
15 24595473 Pseudomonas aeruginosa reduces the expression of CFTR via post-translational modification of NHERF1. 2014 Dec 1
16 24671173 Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice. 2014 1
17 24801204 Reduced blood pressure of CFTR-F508del carriers correlates with diminished arterial reactivity rather than circulating blood volume in mice. 2014 4
18 24898584 Cystic fibrosis transmembrane conductance regulator dysfunction in VIP knockout mice. 2014 Jul 15 1
19 25350163 Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. 2014 1
20 25441013 Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator. 2014 Dec 11 2
21 25500839 Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection. 2014 2
22 23290341 Ventilatory pattern and energy expenditure are altered in cystic fibrosis mice. 2013 Jul 1
23 23346057 Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect. 2013 2
24 23505426 Characterization of nasal potential difference in cftr knockout and F508del-CFTR mice. 2013 4
25 23768658 Modification of the salivary secretion assay in F508del mice--the murine equivalent of the human sweat test. 2013 Dec 1
26 24204804 Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice. 2013 1
27 24367540 Important role of platelets in modulating endotoxin-induced lung inflammation in CFTR-deficient mice. 2013 2
28 22679004 Altered de novo lipogenesis contributes to low adipose stores in cystic fibrosis mice. 2012 Aug 15 1
29 22802588 Rescue of epithelial HCO3- secretion in murine intestine by apical membrane expression of the cystic fibrosis transmembrane conductance regulator mutant F508del. 2012 Nov 1 5
30 23024633 PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis. 2012 5
31 23284872 Rescue of murine F508del CFTR activity in native intestine by low temperature and proteasome inhibitors. 2012 3
32 21301926 Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice. 2011 Jul 1
33 21338920 Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR. 2011 Feb 25 8
34 21723850 Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation. 2011 Aug 5 1
35 19625650 SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. 2009 Aug 15 1
36 19878303 Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone. 2009 Dec 4
37 18006891 Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. 2008 Mar 1 1
38 18309088 Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells. 2008 Jun 4
39 18450781 Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice. 2008 Jul 1 3
40 18955860 Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice. 2008 Nov 1